Related Experiment Video
Updated: Nov 15, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
A Target Antigen-Based Approach to the Classification of Membranous Nephropathy
Shane A Bobart1, Shahrzad Tehranian2, Sanjeev Sethi3
1Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN; Cleveland Clinic Florida, Weston.
Objective:
To describe the clinical and pathological phenotype of membranous nephropathy (MN) associated with M-type-phospholipase-A2-receptor (PLA2R), thrombospondin-type-1-domain-containing-7A (THSD7A), semaphorin 3B (SEMA3B), neural-epidermal-growth-factor-like-1-protein (NELL-1), protocadherin 7 (PCDH7), exostosin 1/exostosin 2 (EXT1/EXT2) and neural cell adhesion molecule 1 (NCAM-1) as target antigens.
Methods:
A retrospective cohort of 270 adult patients with biopsy-proven MN diagnosed between January 2015 and April 2020 was classified as PLA2R-, THSD7A-, SEMA3B-, NELL-1-, PCDH7-, EXT1/EXT2-, NCAM-1-associated or septuple-negative MN using serologic tests, immunostaining, and/or mass spectrometry. Clinical, biochemical, pathologic, and follow-up data were systematically abstracted from the medical records, including disease activity of conditions traditionally associated with MN and occurring within 5 years of MN diagnosis.
Results:
Patients with PLA2R-associated MN were predominantly middle-aged white men without associated disease. The presence of associated disease did not affect the clinical and pathologic characteristics of PLA2R-associated MN, suggesting that they were coincidental rather than causally linked. THSD7A-, NELL-1-, PCDH7-, and NCAM-1-associated MN were rare and SEMA3B-associated MN was not discovered in our cohort. EXT1/EXT2-associated MN was primarily diagnosed in younger women with active systemic autoimmunity. A significant proportion of septuple-negative patients had associated malignancy or systemic autoimmunity.
Conclusion:
The widely used distinction between primary and secondary MN has limitations. We propose a refined terminology that combines the target antigen and associated disease to better classify MN and guide clinical decision making.
Insights
This study characterizes membranous nephropathy (MN) by target antigen, including PLA2R-associated MN in older men and EXT1/EXT2-associated MN in younger women with autoimmunity. A new classification combining antigen and associated disease is proposed for better MN management.
Area of Science:
- Nephrology
- Immunopathology
- Clinical Medicine
Background:
- Membranous nephropathy (MN) classification traditionally relies on primary vs. secondary distinctions, which have limitations.
- Identifying specific target antigens is crucial for understanding MN pathogenesis and clinical presentation.
Purpose of the Study:
- To describe the clinical and pathological phenotypes of MN associated with various target antigens: PLA2R, THSD7A, SEMA3B, NELL-1, PCDH7, EXT1/EXT2, and NCAM-1.
- To propose a refined classification system for MN that integrates target antigen and associated diseases.
Main Methods:
- Retrospective cohort study of 270 adult patients with biopsy-proven MN.
- Classification of MN based on serologic tests, immunostaining, and/or mass spectrometry for target antigens.
- Systematic abstraction of clinical, biochemical, pathological, and follow-up data, including associated conditions.
Main Results:
- PLA2R-associated MN predominantly affected middle-aged white men, with associated diseases often being coincidental.
- EXT1/EXT2-associated MN was observed in younger women with active systemic autoimmunity.
- SEMA3B-associated MN was not found; THSD7A, NELL-1, PCDH7, and NCAM-1 associated MN were rare.
- Septuple-negative MN frequently had associated malignancy or systemic autoimmunity.
Conclusions:
- The distinction between primary and secondary MN is insufficient for comprehensive classification.
- A novel terminology combining target antigen and associated disease offers improved classification and clinical guidance for MN.
- This antigen-based classification aids in understanding the diverse clinical and pathological spectrum of MN.
More Related Videos
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...

